Chromosomal Rearrangements and Cardiac Candidate Genes

染色体重排和心脏候选基因

基本信息

  • 批准号:
    7354823
  • 负责人:
  • 金额:
    $ 47.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-02-01 至 2009-01-31
  • 项目状态:
    已结题

项目摘要

The goal in this proposal is to use chromosomal rearrangements (CRs) occurring in children with CHDs as signposts to identify novel genes important in cardiac morphogenesis. The underlying hypothesis of this proposal is that we can identify genes critical to normal cardiac development based upon their location in relation to breakpoints of balanced translocations. Further, we hypothesize that other chromosomal changes, such as additions or interstitial deletions will assist in the identification of additional dosage sensitive genes important to cardiac development. The subjects for this study will be children who present to the SCCOR with heart defects and possibly further associated congenital anomalies. We will utilize the fruits of the Human Genome Project as well as novel technology we are developing to characterize the regions involved in the chromosomal aberrations of SCCOR patients. We hypothesize that these regions harbor genes important to normal cardiac development. We will pursue the molecular identification and analysis of cardiac candidate genes such that mutation studies can be the focus of subsequent research studies. Characterization of the candidate genes will include the delineation of their tissue, spatial and temporal expression patterns in mouse and/or Xenopus. We will isolate or identify homologues of these candidate genes in model organisms. Our specific aims include: 1) identification and characterization of CRs in patients with CHD by high-resolution cytogenetics and molecular cytogenetic analysis; 2) development of PCR-based mapping strategies using the human genomic sequence to identify translocation breakpoints (BPs); 3) Characterization of the genomic DNA from normal chromosomes at the BPs in order to identify mechanisms of rearrangement; 4) identification and characterization of genes disrupted or deleted at the translocation BPs as candidates for early cardiac morphogenesis; and 5) determination of whether mutations in the candidate genes are associated with the cardiac defect in other patients with CHD. This represents a unified program of clinical and basic research. It brings together the disciplines of clinical cardiology, clinical genetics, cytogenetics, molecular biology and developmental genetics to examine the influence of genomic variation on the etiology of CHDs in our quest to discover genes involved in fundamental pathways during early cardiogenesis.
这项建议的目标是利用发生在先天性心脏病儿童身上的染色体重排(CRS)作为标志,以确定在心脏形态发生中重要的新基因。这一建议的基本假设是,我们可以根据与平衡易位断裂点相关的位置来识别对正常心脏发育至关重要的基因。此外,我们假设,其他染色体改变,如增加或间质缺失,将有助于识别对心脏发育重要的额外剂量敏感基因。这项研究的对象将是向SCCOR提出心脏缺陷和可能进一步相关的先天性异常的儿童。我们将利用人类基因组计划的成果以及我们正在开发的新技术来描述涉及到的地区 SCCOR患者的染色体异常。我们假设这些区域含有对正常心脏发育重要的基因。我们将继续进行心脏候选基因的分子鉴定和分析,以便突变研究可以成为后续研究的重点。候选基因的特征将包括描绘它们在小鼠和/或非洲爪哇中的组织、空间和时间表达模式。我们将在模式生物中分离或鉴定这些候选基因的同源基因。我们的具体目标包括:1)通过高分辨率细胞遗传学和分子细胞遗传学分析来鉴定和表征冠心病患者的CRS;2)利用 这些研究包括:1)确定人类基因组序列以识别易位断裂点;3)鉴定位于易位断裂点的正常染色体的基因组DNA,以确定重排机制;4)鉴定和鉴定易位断裂点上被破坏或缺失的基因,作为早期心脏形态发生的候选基因;以及5)确定候选基因的突变是否与其他冠心病患者的心脏缺陷有关。这代表了临床和基础研究的统一计划。它汇集了临床心脏病学、临床遗传学、细胞遗传学、分子生物学等学科。 生物学和发育遗传学,以检查基因组变异对冠心病病因学的影响,以寻求发现涉及早期心脏发生的基本途径的基因。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BEVERLY S EMANUEL其他文献

BEVERLY S EMANUEL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BEVERLY S EMANUEL', 18)}}的其他基金

Molecular Dissection of the 22q11.2 Deletion Syndrome
22q11.2 缺失综合征的分子解剖
  • 批准号:
    10473894
  • 财政年份:
    2018
  • 资助金额:
    $ 47.45万
  • 项目类别:
Molecular Dissection of the 22q11.2 Deletion Syndrome
22q11.2 缺失综合征的分子解剖
  • 批准号:
    10296523
  • 财政年份:
    2018
  • 资助金额:
    $ 47.45万
  • 项目类别:
Molecular Dissection of the 22q11.2 Deletion Syndrome
22q11.2 缺失综合征的分子解剖
  • 批准号:
    9763601
  • 财政年份:
    2018
  • 资助金额:
    $ 47.45万
  • 项目类别:
2/2 Brain, Behavior and Genetic Studies of the 22q11 Deletion Studies
2/2 22q11 缺失研究的大脑、行为和遗传研究
  • 批准号:
    8690149
  • 财政年份:
    2010
  • 资助金额:
    $ 47.45万
  • 项目类别:
2/2 Brain, Behavior and Genetic Studies of the 22q11 Deletion Studies
2/2 22q11 缺失研究的大脑、行为和遗传研究
  • 批准号:
    8314057
  • 财政年份:
    2010
  • 资助金额:
    $ 47.45万
  • 项目类别:
2/2 Brain, Behavior and Genetic Studies of the 22q11 Deletion Studies
2/2 22q11 缺失研究的大脑、行为和遗传研究
  • 批准号:
    7985951
  • 财政年份:
    2010
  • 资助金额:
    $ 47.45万
  • 项目类别:
2/2 Brain, Behavior and Genetic Studies of the 22q11 Deletion Studies
2/2 22q11 缺失研究的大脑、行为和遗传研究
  • 批准号:
    8479435
  • 财政年份:
    2010
  • 资助金额:
    $ 47.45万
  • 项目类别:
2/2 Brain, Behavior and Genetic Studies of the 22q11 Deletion Studies
2/2 22q11 缺失研究的大脑、行为和遗传研究
  • 批准号:
    8141258
  • 财政年份:
    2010
  • 资助金额:
    $ 47.45万
  • 项目类别:
CORE--MOLECULAR GENETICS CORE
核心--分子遗传学核心
  • 批准号:
    7670393
  • 财政年份:
    2008
  • 资助金额:
    $ 47.45万
  • 项目类别:
Core--Cell Culture, DNA and Microarray
核心--细胞培养、DNA和微阵列
  • 批准号:
    7354825
  • 财政年份:
    2007
  • 资助金额:
    $ 47.45万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 47.45万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 47.45万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 47.45万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 47.45万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 47.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 47.45万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 47.45万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 47.45万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 47.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 47.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了